Rise Therapeutics

The top regional #healthcare and #biotech news for October 24th via the Big4Bio newsletters: San Diego: Daré Bioscience, Inc. Wins $10M ARPA-H Award; MediciNova, Inc.'s Update; Upcoming Events https://lnkd.in/gF923NjT SF Bay: Jade Biosciences Names Execs, Seeks Funding; How Chronic Inflammation Worsens Heart Failure; More on Alto Neuroscience https://lnkd.in/gfY8vEtf Seattle: Omeros Corporation's Zaltenibart Gains FDA's Rare Pediatric Status; Biotech Fundraising Tracker '24; Report Targets 50% Drop in Premature Deaths https://lnkd.in/gSqBZ7Vs Los Angeles: ALS Network Funds RNA Study; Adagio Medical Inc. Hits Milestone in VT Cryoablation Study; MAX BioPharma, Inc. Advances Anti-Fibrotic Therapy https://lnkd.in/gT5sr7TS Boston: Alpha-9 Oncology Raises $175M; Dewpoint Therapeutics, Dyno Therapeutics Strike Deals; Apnimed Hires CFO; More on Boston Scientific https://lnkd.in/g9cghddF Philadelphia: Marinus Pharma's Phase 3 Flop; Integral Molecular Wins $8M Contract; Adaptimmune CEO on The Bio Report https://lnkd.in/gjg9n7up Capital Region: J Taps Bar & Grill Incubator Head; The National Institutes of Health Launches myeloMATCH Trial; Rise Therapeutics Secures Funding https://lnkd.in/gCcrzZQe NYC: Bryn Pharma Appoints CEO; Dimension Capital Management Raising $500M Fund; Advanced Research Projects Agency for Health (ARPA-H) Awards; More on Pfizer https://lnkd.in/gv-jJ6QD

Rise Therapeutics is thrilled to annouce, our Senior Vice President of Research, Christian Furlan Freguia will speak at the upcoming #2024MicrobiomeConnectUSA Christian Furlan Freguia will give insight to the clinical study of R-2487 for Rheumatoid Arthritis: Preclinical Breakthroughs. Demonstrating preclinical models and validation of mechanism on action. Discussing the intricacies and considerations for a genetically modified live biotherapeutic. Early data from the advancement into a phase 1 trial and considerations for clinical due diligence.  📅 Event Date: November 20-21 2024 📍 Location: Boston, USA Click here to join: https://lnkd.in/eRRsDnqd #2024MicrobiomeConnectUSA #biotechnology #sciencetoday #Innovations #Speaker #Research #ClinicalTrial

Rise Therapeutics is excited to share that our Vice President of Development & Manufacturing, Sathya Janardhanan will be speaking at the 12th Microbiome R&D and Business Collaboration Forum! 🌟 Sathya Janardhanan be sharing insights during the "Gut Microbiota for Health and Disease" session, where he will discuss anaerobic development and manufacturing, the tools available for early-stage companies, and strategies for mitigating product development risks. This is a fantastic opportunity to dive into the latest microbiome innovations and collaborate with fellow experts in the field. 📅 Event Date: October 17-18 2024 📍 Location: SAN DIEGO, USA Sathya Janardhanan is looking forward to engaging with fellow professionals and fostering new collaborations to drive impactful change! #Microbiome #R&D #Innovation #BusinessCollaboration #MicrobiomeForum2024 #HealthcareInnovation #Speaker

Rise Therapeutics is thrilled to announce our Senior Vice President of Research, Christian Furlan Freguia, will be leading a crucial roundtable discussion at the upcoming immunotherapies Xchange. Don't miss the chance to dive into the Future of Immunotherapies! #Immunotherapies #MultiOmics #Biotech #hubXchange #Research

Yesterday our team partnered with Montgomery County Economic Development Corporation - Maryland and Maryland Department of Commerce to visit Rise Therapeutics, an innovative biotechnology company in Rockville developing leading-edge treatments for inflammation, autoimmune diseases and cancer using proprietary oral biologics! 📍🧬 💡Discover more about Rise Therapeutics innovative microbiome-based immune therapies at https://lnkd.in/ew7ZNVGm

We are thrilled to share that Gary Fanger, Chief Executive Officer, from Rise Therapeutics, will be presenting as an Expert Speaker at the 9th Microbiome Movement Drug Development Summit, taking place in Boston, US, from 10 to 12 July. He will also contribute to a panel discussion entitled “Defining Innovative Clinical Strategies Conserving Spend” on July 12th at 9:30 AM at the conference. Download the agenda here: https://lnkd.in/gC3VQTXp #MicrobiomeMovement #Microbiome

We are excited to share that Janet Stephens PhD at Rise Therapeutics is on the panel for the 2024 Mountain West BioLife Summit. This summit explores the topics of clinical trial development. You do not want to miss the engaging discussions on key points of clinical trial development from venues and vendors to protocol creation, and more.